The distribution of cells as therapies, as protein factories,^[@ref1]−[@ref3]^ and in basic biomedical research is underpinned by their cryopreservation to enable storage and distribution. This is essential as cells cannot be maintained in continuous culture due to the resulting genetic and phenotypic drift.^[@ref4]^ Current cryopreservation protocols for mammalian cells rely on the addition of high concentrations of dimethyl sulfoxide (DMSO) as the cryoprotective agent (CPA). While widely used, DMSO does not give full recovery of all cells post-thaw (leading to wastage) and is intrinsically cytotoxic (leading to further cell death if left in contact).^[@ref5]−[@ref7]^ DMSO does not protect against all mechanisms of cell death (e.g., mechanical damage caused by ice recrystallization^[@ref8]^). It is therefore desirable to reduce the amount of DMSO used in cryoprotective solutions. To address this issue, macromolecular cryoprotectants inspired by antifreeze (glyco) proteins or late embryogenesis abundant proteins are emerging.^[@ref9]−[@ref11]^ Polymers which control ice recrystallization have been found to give some benefit during cryopreservation of various cell lines, but this effect is limited in mammalian cells.^[@ref12]^ However, it is emerging that polyampholytes (polymers with a balance of cationic and anionic side chains) are extremely potent cryopreservation enhancers despite only having moderate ice recrystallization inhibition (IRI) activity^[@ref13],[@ref14]^ compared to, e.g., poly(vinyl alcohol) or other inhibitors.^[@ref15]−[@ref17]^ Polyampholytes have been shown to be remarkably potent cryoprotectants for many cell types including mesenchymal stem cell (MSC) monolayers,^[@ref18]^ chondrocyte sheets,^[@ref19]^ and human MSCs.^[@ref20]^ However, their mode of action remains unclear, in part due to the lack of structure--property relationships. There is some evidence that polyampholytes engage and protect cell membranes, but this is not proven as their mode of cryoprotection.^[@ref14],[@ref18]^

In any biomimetic material, a key challenge is the exploration of sufficiently large chemical space (100s of materials) to enable key structural motifs to be identified. This is a particular challenge in macromolecular cryoprotectants due to their diverse modes of action and paucity of published structures of active materials. Alexander and co-workers have used microarray printing and UV-photocuring to explore 1000s of copolymers to identity surfaces suitable for resisting bacterial adhesion and for the expansion of stem cells.^[@ref21]^ Schubert and co-workers exploited liquid handling systems for automated cationic and radical polymerizations.^[@ref22]^ However, this required significant infrastructure and robust handling methods to exclude oxygen, which prematurely terminates radical polymerizations. Recently, there has been a revolution in oxygen-tolerant controlled radical polymerization methods,^[@ref23]^ for example, protein^[@ref24]^ or tertiary amine degassing,^[@ref25]^ breathing ATRP,^[@ref26]^ and PET-RAFT.^[@ref27]^ A benefit of these methods is that little infrastructure is required to conduct the reactions in industry-standard multiwell plates; almost all biological testing is conducted in 96-well plates. Richards et al. utilized blue-light-initiated open-air RAFT photopolymerization to identify new antimicrobial polymers.^[@ref28]^ Chapman and co-workers used oxygen-tolerant PET-RAFT to make a library of 18 lectin binding materials.^[@ref27]^ There are currently no detailed structure--activity relationships in the field of macromolecular cryoprotectants which is preventing the rational design of new materials.

This manuscript describes the first biomaterials discovery approach to identify macromolecular cryoprotectants. Using liquid-handling systems and photo-RAFT polymerization, a library of polymers were synthesized, characterized, and screened for cryopreservation. A new cryoprotectant terpolymer was discovered which enabled nucleated cell cryopreservation with reduced \[DMSO\].

2-(Dimethylamino)ethyl methacrylate (DMEAMA) and methacrylic acid (MAA) were selected as the cationic/anionic components based on previous reports.^[@ref14],[@ref29]^ Initial screening ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)) identified that an excess of DMEAMA compared to MAA leads to improved cryopreservation in an erythrocyte model, so a 6:4 DMEAMA:MAA ratio was used. To enable high-throughput polymer synthesis, liquid-handling robots were used to distribute reagents within 96-well plates, which is also the format for the cryopreservation testing. Blue-light-mediated polymerization using a trithiocarbonate and triethanolamine (TEOA) as the degassing agent was employed ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A).^[@ref25],[@ref30]^ \[Controls on the role of TEOA are in [Figures S4/5](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)\]. To tune the polyampholyte, a panel of 12 (uncharged) comonomers were selected ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B). These were distributed by the liquid-handling system at 2--20 mol % with DMEAMA/MAA. An amount of 20 mol % was the upper limit to ensure solubility of the library. Polymerizations were conducted in 96-well plates under blue-light irradiation and then dried under a vacuum. \[Note this method gives larger dispersities than a true CRP process.^[@ref31]^\] A fraction was removed for size exclusion chromatography (SEC), revealing monomodal distributions and reproducible molecular weights within each polymer class ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B and [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)).

![(A) Combinatorial photopolymerization strategy employed here. (B) SEC analysis of the polymer library. Number indicates comonomer used. Polymers were synthesized at a \[M\]:\[CTA\] ratio of 100:1.](mz0c00044_0001){#fig1}

Erythrocytes (red blood cells) are a useful model system for cryopreservation, as when damaged, heamoglobin leaks, which can be measured by the alkaline hemeatin detergent (AHD) assay, suitable for plate-based analysis.^[@ref32]^ A sample of polymer from the polymerization plate (at 140 mg·mL^--1^ in 700 μL of PBS) was transferred directly into the corresponding wells of a 96-well plate and diluted to 71 mg·mL^--1^ by the addition of red blood cells suspended in PBS. This mixture was then frozen in liquid nitrogen vapor and thawed at 45 °C, and any intact cells and debris were removed by centrifugation of the plate. The supernatant was sampled into AHD solutions and hemolysis measured on a plate reader at 580 nm. All 120 polymers were assessed for cryopreservation capability in triplicate, and the results are summarized in the heat map shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B.

![High-throughput screening of cryopreservation against erythrocytes. (A) Schematic of liquid transfer and screening conditions. (B) Heat map showing post-thaw erythrocyte recovery outcomes (recovery = 1-heamolysis) using 71 mg·mL^--1^ of polymer. Recoveries are average of three repeats (individual data in [SI](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)). Monomer structures are in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}.](mz0c00044_0002){#fig2}

[Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B reveals the essential need for high-throughput screening in this emerging field; nonlinear relationships between mol % comonomer and recovery were observed, meaning hits would be missed when using traditional small panels of polymers. For example, using comonomer 1 (PEG methacrylate), at 8 or 14 mol %, led to increased recovery, compared to 10 mol % which led to a significant reduction---a feature which could easily be missed in targeted synthesis. Octanol/water partition coefficients, normalized to surface area (log *P*/SA), were calculated using oligomers of the comonomers and reported in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B,^[@ref33],[@ref34]^ revealing no clear correlation. This demonstrated that any assumptions of "more hydrophobic is better" are oversimplified and limited by the current lack of understanding of how polyampholytes function.^[@ref18],[@ref35]^ This should be appropriately described as hydrophobicity is beneficial to a point and should be experimentally verified.^[@ref18]^ The most active polymer identified contained 4 mol % of hydroxyethyl methacrylate (**4**), with other levels of incorporation also giving significant cell recovery. In contrast, the excessive hydrophobicity of cyclohexyl methacrylate (**11**) resulted in the worst performance.

The best and worst polymers from the cryopreservation screen (4% HEMA and 10% CyMA, respectively) were taken forward to test in a nucleated cell model, using well-defined polymers to validate the screening approach. The hit terpolymers were synthesized targeting different DPs, using conventional RAFT polymerization ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), and characterized by SEC, NMR, and IR ([SI](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)). In an erythrocyte cryopreservation assay, these polymers performed as in the screen ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C), confirming the initial results. Importantly, the hit (4% HEMA) terpolymer was a better cryoprotectant than the copolymer without additional monomers ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)).

###### Hit Polymers Synthesized by RAFT

  polymer[a](#t1fn1){ref-type="table-fn"}   \[M\]/\[CTA\][b](#t1fn2){ref-type="table-fn"} (−)   conversion (%)[c](#t1fn3){ref-type="table-fn"}   Mn~(Theo)~[d](#t1fn4){ref-type="table-fn"} (g mol^--1^)   Mn~(SEC)~[e](#t1fn5){ref-type="table-fn"} (g mol^--1^)   *D̵*[e](#t1fn5){ref-type="table-fn"}
  ----------------------------------------- --------------------------------------------------- ------------------------------------------------ --------------------------------------------------------- -------------------------------------------------------- -------------------------------------
  4% HEMA~50~                               50                                                  100                                              6400                                                      10 000                                                   1.48
  4% HEMA~100~                              100                                                 97                                               12 000                                                    15 000                                                   1.57
  4% HEMA~200~                              200                                                 98                                               25 000                                                    15 000                                                   1.84
  10% CyMA~100~                             100                                                 96                                               12 000                                                    16 000                                                   1.39

Polymers labeled based on comonomer incorporation ratio into a 6:4 DMEAMA:MA copolymer.

Monomer:CTA ratio.

Determined by ^1^H NMR.

Based on feed ratio and conversion.

From DMF SEC.

![Hit polymers and their cryoprotective properties. (A) Polymers obtained by conventional RAFT polymerization. (B) Ice recrystallization inhibition activity of hit polymers (20 mg·mL^--1^, MGS = mean grain size, dotted line = PEG 20 mg·mL^--1^ control). (C) Red blood cell post-thaw recovery. (D) Post-thaw recovery of A549 cells with intact membranes using 2.5 wt % of DMSO/20 mg·mL^--1^ of polymer against control of 2.5 wt % of DMSO alone. (E) Segmented partition coefficient analysis. Colors represent monomers in Part A. Squares are HEMA; triangles are CyMA; and circles are DMAEMA/MAA. Highlighted areas show net positive or negative log *P*/SA.](mz0c00044_0003){#fig3}

A549 (human Caucasian lung carcinoma) cells were next used as a more challenging model of cryopreservation to assess the hit polymers, selected from the red blood cell cryopreservation screen. A549 cryopreserved in 10 wt % DMSO yields \>60% recovery post-thaw. However, exposure of A549s to 10 wt % of DMSO for just 30 min leads to a 30% drop in metabolic activity.^[@ref14]^ We therefore explored cryopreservation using just 2.5 wt % of DMSO with our polymers added at 20 mg·mL^--1^ to explore their ability to rescue cell recovery in minimal DMSO. After thawing, the cells were allowed to recover for 24 h before the total number of viable cells was counted ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}D). \[24 h recovery post-thaw removes false positives due to apoptosis.\]^[@ref36]^ Copolymers with 4% HEMA showed enhancements in post-thaw cell recovery increasing from 15% for DMSO (2.5 wt %) to above 40%. In contrast, the 10% CyMA copolymers gave worse results than DMSO alone. This shows that polyampholytes are not universal scaffolds and that additional structural features modulate activity. DP100 HEMA was more potent than DP50 or 200 showing that the macromolecular structure is important with the longer polymer performing poorly in this assay. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}E (and [S1](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)0/11) shows oligomer models of the most/least active copolymers and the segmental LogP/SA values (rather than a crude average across the whole polymer). Localized regions of hydrophobic content (positive log *P*/SA) correlated with poor cell recovery, but hydrophilic regions exhibited better performance. This observation may explain why alternating (evenly distributed hydrophobicity) polyampholytes are potent cryopreservatives and also have more IRI activity compared to random.^[@ref13],[@ref14]^ None of the polymers showed significant IRI activity^[@ref16]^ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B) ruling out ice-growth inhibition as a mode of action.^[@ref37]^ The recoveries obtained here are not as high as a previously reported poly(ampholyte)^[@ref14]^ but rather show the opportunity to modulate activity and determine the important structural features. Dynamic light scattering (DLS) showed that 10% CyMA polymers aggregated but that the 4% HEMA aggregated less. This demonstrates that although hydrophobicity can help, aggregation negates the benefits: this could lead to reducing the effective concentrations of the polymers or simply preventing efficient membrane interactions (a hypothesis we highlight is not confirmed).

To further test how the polymers protect cells, carboxyfluorescein-loaded 1,2-dioleoyl-*sn*-glycero-3- phosphocholine liposomes (100 nm) were prepared ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)) to enable evaluation of cryoprotection in a lipid-only system. The most active cellular cryoprotectant (4% HEMA~100~) protected liposomes against freezing, equally well as a control polyampholyte ([Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf)). The most hydrophobic polymer (10% CyMA~100~) failed to provide protection, which is in contrast to the results of Matsumura et al.^[@ref18]^ This does not rule out hydrophobicity being beneficial but rather that multiple factors are influencing cryopreservation outcomes including the aggregation state of the materials, and hence a fine balance is required. Antifreeze proteins have been reported to protect membranes and may be a related mechanism of action.^[@ref38]^ Osmotic effects on cryopreservation due to the use of a polyelectrolyte cannot be ruled out. However, the clear impact of comonomers and chain length on the observed cryopreservation outcomes suggests it is more complex and that a single mechanism may not be responsible.

In summary, we have used a high-throughput discovery platform to identify polyampholyte terpolymers, which are capable of reducing the volume of organic solvents required for cellular cryopreservation. High-throughput oxygen-tolerant photo-RAFT polymerization generated a library of 120 polyampholytes. Screening of this library for red blood cell cryopreservation enabled identification of hits, with terpolymers containing just 4 mol % of hydroxyethyl methacrylate showing particularly high activity. "Hit" terpolymers enhanced cryopreservation of a nucleated cell model using just 2.5 wt % of DMSO, rather than the conventional 10 wt %. The polymers did not function by inhibiting ice growth, but there was some evidence that they can stabilize model membranes. Modeling showed that the most active polymers had negative surface-area-normalized partition coefficients across most segments. Overall, this study shows that by exploring the chemical space of polyampholytes it may be possible to discover new macromolecular cryoprotectants and access structure--property relationships to help understand how they function.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsmacrolett.0c00044](https://pubs.acs.org/doi/10.1021/acsmacrolett.0c00044?goto=supporting-info).Experimental details and characterization as well as additional data ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsmacrolett.0c00044/suppl_file/mz0c00044_si_001.pdf))
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